HTS Library for Drug Discovery

Catalog No.L5000

A unique collection of 99008 compounds features numerous structurally diverse compounds and several alternate compositions.

384 well plates

Cited by 2 Publications

HTS Library for Drug Discovery Contents

If you need to download the HTS Library for Drug Discovery Contents (.xlsx and .sdf), please contact us via info@selleckchem.com

Description & Advantages

• A unique collection of 99008 compounds features numerous structurally diverse compounds and several alternate compositions, which is used for high throughput screening (HTS) and high content screening (HCS)

• Molecules' weights range from 300 to 500, potential drug-likeness and druggability, easy to find active molecules and improve the efficiency of new drug screening

• Innovative compounds from 50 years’ research of the largest pharmaceutical company

 

Product Details

Formulation 99008 compounds pre-dissolved in 10mM DMSO
Container 384 Deep Well Plate Sealed With Aluminum Foil
Stability 12 months -20°C in DMSO
24 months -80°C in DMSO
Shipping Blue ice or dry ice

Case Studies using Selleck Compound Libraries

  • Application of GPCR Compound Library in liver cancer (This article was published in Nature (IF=43) and took about 15 months):

    Nature.2019;574(7777):268-272

  • Application of Kinase Inhibitor Library in colorectal cancer (This article was published in Nature Communications (IF=11) and took about 8 months):

    Nat Commun. 2019 16;10(1):2197

  • Application of FDA-approved Drug Library in antivirus (This article was published in Cell Research (IF=17) and took about 13 months):

    Cell Res. 2019;29(9):739-753

  • Application of FDA-approved Drug Library in metabolism (This article was published in Movement Disorders (IF=8) and took about 10 months):

    Mov Disord. 2019;34(3):323-334

  • Application of Epigenetics Compound Library in acute lymphoblastic leukemia (This article was published in Blood (IF=16) and took about 16 months):

    Blood. 2019 17;134(16):1323-1336

  • Application of Inhibitor Library in tumor immunology (This article was published in Cancer Immunol Res (IF=8.6) and took about 12 months):

    Cancer Immunol Res.2017;5(9):790-803

HTS Library for Drug Discovery Composition

HTS Facility Partners

  • Collaborating with Seleck: Yale University | Yale Center for Molecular Discovery
  • Collaborating with Seleck: Carbone Cancer Center | University of Wisconsin-Madison
  • Collaborating with Seleck: University of Colorado Denver | CU Denver
  • Collaborating with Seleck: Leibniz-Forschungsinstitut für Molekulare Pharmakologie: Leibniz-FMP
  • Collaborating with Seleck: UCSF_University of California San Francisco
  • Collaborating with Seleck: KU | High Throughput Screening Laboratory
  • Collaborating with Seleck: CIBIO
  • Collaborating with Seleck: Perelman school of medicine | University of Pennsylvania